CIBC Bancorp USA’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147M Sell
381,188
-81,239
-18% -$30.1M 0.18% 134
2026
Q1
$135M Buy
+462,427
New +$152M 0.18% 124
2025
Q3
$10M Buy
+31,094
New +$9.67M 0.05% 255

Other funds holding ELV

CIBC Bancorp USA's ELV Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Elevance Health (ELV) stake by 18% in Q2 2026, selling an estimated $30.1M and leaving 381,188 shares worth $147M. The position accounts for 0.18% of the portfolio, ranked #134.

CIBC Bancorp USA first reported a position in ELV in Q3 2025 and has held it in 3 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • CIBC Bancorp USA held 381,188 shares of Elevance Health worth $147M as of Q2 2026.
  • CIBC Bancorp USA sold 81,239 Elevance Health shares in Q2 2026, an estimated $30.1M.
  • Elevance Health made up 0.18% of CIBC Bancorp USA's portfolio in Q2 2026, its #134 holding.
  • CIBC Bancorp USA first reported a position in Elevance Health in Q3 2025 and has held it in 3 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.